Tirzepatide is a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://rebeccafgny781613.ka-blogs.com/93979483/tirzepatide-a-game-changer-for-type-2-diabetes